2025-04-04 19:35:40
Latest Post
Sai Life Sciences sets up Peptide Research Center in India
Netweb Technologies Ltd receives PLI Incentive Under IT Hardware Scheme 2.0
BHEL signs contract for ± 800 kV, 6000 MW Bhadla-Fatehpur LCC HVDC Terminal Station along with AC Transmission at Bhadla and Fatehpur
DEE Development Engineers Limited receives order worth approx. Rs. 55 crores- SURATWWALA BUSINESS GROUP Ltd purchases new commercial office space
Stock Report
Astec LifeSciences Ltd consolidated Q3FY23 PAT slumps to Rs. 83.97 lakhs
Posted On : 2023-01-30 23:38:37( TIMEZONE : IST )
Astec LifeSciences Limited has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 120.9697 crores during the period ended December 31, 2022 as compared to Rs. 203.7329 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 0.8397 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 18.3082 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 0.43 for the period ended December 31, 2022 as compared to Rs. 9.34 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹120.9697 crs | ₹203.7329 crs |  -40.62% |
| Net Profit | ₹0.8397 crs | ₹18.3082 crs | -95.41% |
| EPS | ₹0.43 | ₹9.34 | -95.40% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.120.9697 crores during the period ended December 31, 2022 as compared to Rs.175.3130 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.0.8397 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.24.7468 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.0.43 for the period ended December 31, 2022 as compared to Rs.12.62 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹120.9697 crs | ₹175.3130 crs | -31.00% |
| Net Profit | ₹0.8397 crs | ₹24.7468 crs | -96.61% |
| EPS | ₹0.43 | ₹12.62 | -96.59% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.511.6793 crores during the 9 Months period ended December 31, 2022 as compared to Rs.408.2471 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.30.5478 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.46.8040 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.15.58 for the 9 Months period ended December 31, 2022 as compared to Rs.23.88 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹511.6793 crs | ₹408.2471 crs |  25.34% |
| Net Profit | ₹30.5478 crs | ₹46.8040 crs | -34.73% |
| EPS | ₹15.58 | ₹23.88 | -34.76% |
Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 1521.10 as compared to the previous close of Rs. 1544.80. The total number of shares traded during the day was 398 in over 145 trades.
The stock hit an intraday high of Rs. 1591.30 and intraday low of 1520.00. The net turnover during the day was Rs. 619677.00.
